Advertisements



Two Catalysts For Axovant Sciences In March

Two Catalysts For Axovant Sciences In March.....»»

Category: topSource: seekingalphaFeb 11th, 2019

Upcoming Catalysts Make Axovant Attractive, Jefferies Says In Upgrade

Axovant Sciences Ltd (.....»»

Category: blogSource: benzingaDec 17th, 2018

Major 2019 Biopharma Catalysts Coming in February and March

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March......»»

Category: blogSource: 247wallstFeb 8th, 2019

Axovant Sciences reports Q3 EPS (27c), consensus (26c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 7th, 2019

March 1st Options Now Available For EXACT Sciences (EXAS)

Stock Options Channel.....»»

Category: topSource: redinewsJan 10th, 2019

Andreas Halvorsen Takes Large Stake in Axovant Sciences

Guru sees value in biotech companyCheck out Andreas Halvorsen Stock Picks » Download GuruFolio Report of Andreas Halvorsen (Updated on 12/20/2018)Related Stocks: AXON, BPMC, BMRN, ANAB, JAZZ, EDIT, EIDX, LIFE, DCPH, ABEO,.....»»

Category: blogSource: gurufocusDec 21st, 2018

Axovant Sciences upgraded to Buy from Hold at Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

Axovant Sciences 30M share Spot Secondary priced at $1.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Axovant Sciences files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Axovant Sciences licenses two gene therapies from UMass Medical School

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

UPDATE: Axovant shares slide 30% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 30% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

Axovant Sciences nelotanserin Phase 2 study does not meet primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 10th, 2018

Axovant shares slide 24% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 24% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

Axovant Sciences announces feedback from AXO-Lenti-PD pre-IND meeting with FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 6th, 2018

Axovant Sciences doses first patient in AXO-Lenti-PD clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

What Is Going On At Axovant Sciences?

What Is Going On At Axovant Sciences?.....»»

Category: topSource: seekingalphaAug 15th, 2018

After five months on job, Gilead chief medical officer joins exodus

Dr. Andrew Cheng, appointed in March as chief medical officer of Gilead Sciences Inc., is leaving the company, joining an exodus of top-level executives from the Foster City-based drug developer. Cheng will "pursue another opportunity," Gilead (NA.....»»

Category: topSource: bizjournalsAug 14th, 2018

Axovant Sciences reports Q1 EPS (48c), consensus (18c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Axovant Sciences Failed To Mention Critical Information

Axovant Sciences Failed To Mention Critical Information.....»»

Category: topSource: seekingalphaJul 15th, 2018

Axovant Sciences (AXON) Updates on Global Licensing Agreement for AXO-AAV-OPMD & Broader Platform Collaboration with Benitec Biopharma - Slideshow

Axovant Sciences (AXON) Updates on Global Licensing Agreement for AXO-AAV-OPMD & Broader Platform Collaboration with Benitec Biopharma - Slideshow.....»»

Category: topSource: seekingalphaJul 10th, 2018

Axovant Wins With Key Licensing Agreement

Axovant Sciences shares saw a handy gain on Monday after the company announced that it has licensed exclusive global rights to an investigational gene therapy program from Benitec Biopharma......»»

Category: blogSource: 247wallstJul 9th, 2018